aana glp-1 guidelines A very important and practice-changing consensus statement from the British Journal of Anaesthesia on perioperative management of patients taking receptor agonists such as semaglutide, tirzepatide, and liraglutide. The key message is GLP-1 and Anesthesia: Considerations and

When administered, these medications work through several mechanisms: Slowing gastric emptying - Food remains in the stomach longer, which can contribute to feelings of fullness Reducing appetite signaling - The medications act on brain regions involved in hunger and satiety Improving insulin secretion - In response to food intake, insulin release becomes more efficient, which is why these medications were originally developed for diabetes Decreasing glucagon secretion - This hormone raises blood sugar, so reducing it helps with glucose control The two primary GLP-1 receptor agonists used for weight loss are: Semaglutide - FDA-approved for weight management under the brand name Wegovy (also sold as Ozempic for diabetes and Rybelsus as an oral diabetes medication)

Hong, S

It works by: Enhancing feelings of fullness Slowing gastric emptying Reducing appetite These mechanisms not only support weight loss but also improve metabolic health

Its very unusual to see the extended shortage of a multi-billion dollar drug, leading to the funky dynamics were seeing DTC telehealth players (and in-person med spas, other wellness facilities) want to maximize their economics by expanding access to acquire/grow subscriber bases

Injecting into problem areas : Avoid scarred, bruised, or inflamed skin to ensure proper absorption

According to BMI charts, Im still in the obesity range and need to lose another 90 pounds to drop below the overweight category for my height